Check out the stocks that are attracting the most attention and driving market activity.
Gossamer Bio Inc GOSS
$0.17
βΌ -4.94%
($-0.01)
🎢 High Beta
📅 Earnings This Week
Open
$0.18
Prev Close
$0.18
Day Range
$0.17 β $0.18
52W Range
$0.11 β $3.87
Market Cap
$82.86M
Beta
2.02
EPS (TTM)
$-0.78
π Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2019-02-08 |
| Shares Out. | 488,850,000 |
| Website | gossamerbio.com/ β |
| Phone | 13026365400 |
| Employees | 162 |
| Revenue | $17.0M |
| Gross Profit | $17.0M |
| Net Income | -$46.7M |
| Free Cash Flow | -$170.3M |
| Total Assets | $128.9M |
| Total Liabilities | $290.4M |
| Equity | -$161.5M |
About Gossamer Bio Inc
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).
Gossamer Bio Inc is a publicly traded company under the ticker symbol GOSS on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
π Analyst Ratings
14 analysts (2026-07-01)
π° Latest News for GOSS
Which stocks are moving before the opening bell on Tuesday?
This Crowdstrike Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
This Honeywell Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Tuesday
Leerink Partners Upgrades Gossamer Bio to Outperform, Maintains Price Target to $1
Why Celestica Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
Top movers in Monday's after hours session

